INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 26 | -98.3% | 0.00% | – |
| Q2 2017 | $2,000 | -60.0% | 1,501 | +1.8% | 0.00% | – |
| Q1 2017 | $5,000 | +150.0% | 1,475 | +6.7% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 1,382 | -10.3% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 1,540 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -77.8% | 1,540 | -6.6% | 0.00% | – |
| Q1 2016 | $9,000 | -35.7% | 1,648 | -7.4% | 0.00% | – |
| Q4 2015 | $14,000 | -6.7% | 1,780 | 0.0% | 0.00% | – |
| Q3 2015 | $15,000 | – | 1,780 | +4464.1% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 39 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | – | 39 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 39 | -97.4% | 0.00% | -100.0% |
| Q4 2013 | $21,000 | +31.2% | 1,500 | +50.0% | 0.00% | 0.0% |
| Q2 2013 | $16,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |